de Las Pozas A - Search Results

1

Inhibiting Multiple Deubiquitinases to Reduce Androgen Receptor Expression in Prostate Cancer Cells.

de Las Pozas A, Reiner T, De Cesare V, Trost M, Perez-Stable C. de Las Pozas A, et al. Sci Rep. 2018 Sep 3;8(1):13146. doi: 10.1038/s41598-018-31567-3. Sci Rep. 2018. PMID: 30177856 Free PMC article.

2

Increased expression of cyclin B1 sensitizes prostate cancer cells to apoptosis induced by chemotherapy.

Gomez LA, de Las Pozas A, Reiner T, Burnstein K, Perez-Stable C. Gomez LA, et al. Among authors: de las pozas a. Mol Cancer Ther. 2007 May;6(5):1534-43. doi: 10.1158/1535-7163.MCT-06-0727. Mol Cancer Ther. 2007. PMID: 17513602

3

NF-kappaB activation enhances cell death by antimitotic drugs in human prostate cancer cells.

Parrondo R, de las Pozas A, Reiner T, Rai P, Perez-Stable C. Parrondo R, et al. Among authors: de las pozas a. Mol Cancer. 2010 Jul 9;9:182. doi: 10.1186/1476-4598-9-182. Mol Cancer. 2010. PMID: 20618955 Free PMC article.

4

Betulinic acid selectively increases protein degradation and enhances prostate cancer-specific apoptosis: possible role for inhibition of deubiquitinase activity.

Reiner T, Parrondo R, de Las Pozas A, Palenzuela D, Perez-Stable C. Reiner T, et al. Among authors: de las pozas a. PLoS One. 2013;8(2):e56234. doi: 10.1371/journal.pone.0056234. Epub 2013 Feb 12. PLoS One. 2013. PMID: 23424652 Free PMC article.

5

Sequential combination of flavopiridol and docetaxel reduces the levels of X-linked inhibitor of apoptosis and AKT proteins and stimulates apoptosis in human LNCaP prostate cancer cells.

Gomez LA, de Las Pozas A, Perez-Stable C. Gomez LA, et al. Among authors: de las pozas a. Mol Cancer Ther. 2006 May;5(5):1216-26. doi: 10.1158/1535-7163.MCT-05-0467. Mol Cancer Ther. 2006. PMID: 16731754

6

Sequential combinations of flavopiridol and docetaxel inhibit prostate tumors, induce apoptosis, and decrease angiogenesis in the Ggamma/T-15 transgenic mouse model of prostate cancer.

Reiner T, de las Pozas A, Perez-Stable C. Reiner T, et al. Among authors: de las pozas a. Prostate. 2006 Oct 1;66(14):1487-97. doi: 10.1002/pros.20478. Prostate. 2006. PMID: 16921509

7

Progression of prostate cancer from a subset of p63-positive basal epithelial cells in FG/Tag transgenic mice.

Reiner T, de Las Pozas A, Parrondo R, Perez-Stable C. Reiner T, et al. Among authors: de las pozas a. Mol Cancer Res. 2007 Nov;5(11):1171-9. doi: 10.1158/1541-7786.MCR-07-0024. Epub 2007 Nov 2. Mol Cancer Res. 2007. PMID: 17982114 Free article.

8

Low dose combinations of 2-methoxyestradiol and docetaxel block prostate cancer cells in mitosis and increase apoptosis.

Reiner T, de las Pozas A, Gomez LA, Perez-Stable C. Reiner T, et al. Among authors: de las pozas a. Cancer Lett. 2009 Apr 8;276(1):21-31. doi: 10.1016/j.canlet.2008.10.026. Epub 2008 Nov 28. Cancer Lett. 2009. PMID: 19046802

9

ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells.

Parrondo R, de Las Pozas A, Reiner T, Perez-Stable C. Parrondo R, et al. Among authors: de las pozas a. PeerJ. 2013 Sep 12;1:e144. doi: 10.7717/peerj.144. eCollection 2013. PeerJ. 2013. PMID: 24058878 Free PMC article.

10

Mcl-1 protects prostate cancer cells from cell death mediated by chemotherapy-induced DNA damage.

Reiner T, de Las Pozas A, Parrondo R, Palenzuela D, Cayuso W, Rai P, Perez-Stable C. Reiner T, et al. Among authors: de las pozas a. Oncoscience. 2015 Sep 1;2(8):703-15. doi: 10.18632/oncoscience.231. eCollection 2015. Oncoscience. 2015. PMID: 26425662 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters